About Vakzine Projekt Management
VPM offers tailor-made consultancy and services based on in-depth experience in development of biopharmaceutical candidates. In addition, VPM acquires promising candidates from academic research and develops them in cooperation with a pool of partners to products with a high value potential. The company was established in 2002 following an initiative of the German Federal Ministry of Education and Research to promote the German market by funding vaccine development.
Within the last decade, VPM has successfully managed and consulted the development of promising biopharmaceutical candidates, ranging from small molecules, recombinant proteins up to gene-modified live vaccines and ATMPs from academic research and brought them into clinical phase I and II trials.More about us
News & Press
This year's conference topic is "15 Years VPM - from Target to Market". The presentations during the event will address critical factors for successful translational research and development.
VPM will be present at the 6th International Congenital CMV Conference / 16th International CMV/betaherpesvirus Workshop in Noordwiijkerhout, the Netherlands from Mar 30 to May 4 2017.
First results of the VPM1002BC clinical Phase I/II study will be presented at the international congress of the European Association of Urology 2018 in Copenhagen, Denmark that will take place from 16. to 20.03.2018.
VPM is searching for a Quality Assurance Assistant to support the maintenance of the internal Quality Management System (QMS). VPM operates in the regulatory framework of ICH, the European Union and Germany. Therefore, …